A catch up with Biogen’s new legal and compliance officer

Four months into his new role at US biotechnology multinational Biogen, Silvio Fachim talks to LACCA about how he prioritises his day-to-day activities, balancing a corporate culture with technology, and Biogen’s struggle to get its drugs on the Brazilian market.


Get unlimited access to all Latin Lawyer content